Pancreatin is a digestive enzyme naturally produced by the pancreas. It is a mixture of amylase, lipase, and protease, which are secreted into the small intestine to help break down proteins, carbohydrates, and fats. Pancreatin is sometimes used as a supplemental enzyme to help treat or prevent conditions caused by inadequate enzyme production in the body, such as pancreatitis, cystic fibrosis, and malabsorption syndromes.
Pancreatin is widely used in many parts of the world today. It is available as a dietary supplement in the United States and several European countries, as well as in tablets and capsules in Asian countries such as China and India. It is also used as a therapeutic supplement in clinical settings for digestive conditions.
The global Pancreatin market was valued at US$ 138 million in 2022 and is anticipated to reach US$ 184.7 million by 2029, witnessing a CAGR of 4.2% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
A detailed market research report on Global Pancreatin Market available at: https://www.themarketreports.com/report/global-pancreatin-market-research-report
This report aims to provide a comprehensive presentation of the global market for Pancreatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pancreatin.
Global Pancreatin key players include Shenzhen Hepalink, Nordmark, Sichuan Deebio, Sichuan Biosyn, Chongqing Aoli, etc. Global top five manufacturers hold a share over 60%.
Ask for more details or sample of this report at: https://www.themarketreports.com/report/ask-your-query/1391974
Release by:
Shirish Gupta
Marketing Manager
The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com